Homocysteine Expert Panel e.V.
Universitätsklinikum des Saarlandes, Klinische Chemie und Laboratoriumsmedizin
Zentrallabor, Geb. 57, D-66421 Homburg/Saar

Current issues

Advances and Controversies in B-Vitamins and Choline - CONFIRMED SPEAKERS
CONFIRMED SPEAKERS
Preliminary Programme
Plenary Session 1 • Advances in Cobalamin Research
New insights into cobalamin absorption and metabolism using accelerator mass spectrometry
Ralph Green (Davis, CA/US)
Vitamin B12 and its binding proteins
Ebba Nexo (Aarhus/DK)
Advances In Cobalamin Research: Targeting The Transcobalamin Receptor TCblR/CD320
Edward Quadros (New York/US)
Insights into functional cobalamin deficiency: the MMACHC proteome
Luciana Hannibal (Cleveland/US)
Plenary Session 2 • Transsulfuration and Gluathione metabolism
New insights into cobalamin absorption and metabolism using accelerator mass spectrometry
Ruma Banerjee (Ann Arbor, US)
Hydrogen sulfide and oxygen sensing
Kenneth R. Olson (South Bend/US)
Inflammatory markers, kynurenines and vitamin B6 in relation to chronic disease
Simone Eussen (Bergen/NO)
Cystathionine gamma-lyase dependent H2S formation in perivascular adipose tissue in experimental metabolic syndrome
Jerzy Beltowski (Lublin/PO)
Plenary Session 3 • Vitamin B6 and Riboflavin
Vitamin B-6 and folate affect the association between MAT1A variants and hypertension, stroke, and markers of DNA damage
Chao Qiang Lai (Boston/US)
Role of Vitamin B6 and its Metabolite in Ca2+-handling and Cardiac Function
Naranjan S. Dhalla (Winnipeg, CA)
Riboflavin as a determinant of iron status
Hilary Powers (Sheffield/UK)
Plenary Session 4 • B-Vitamins and age-associated diseases: Neurology
Antiepileptic drugs and B-Vitamins: epidemiological and electrophysiological data
Michael Linnebank (Zurich/CH)
Normal prions as a new target of cobalamin deficiency in rat CNS
Guiseppe Scalabrino (Milan/IT)
Mechanisms of Neurological complications in HHCY
Aron Troen (Rehovot/IL)
Plenary Session 5 • B-Vitamins and age-associated diseases: Osteoporosis
Osteoporosis – New Diagnostic and Clinical Aspects
Markus Herrmann (Penrith/AU)
Altered bone structure and decreased bone formation, the role of B-vitamins and homocystein
Jörg Holstein (Homburg/Saar/DE)
Homocysteine mediated decrease in bone blood flow and remodeling: Role of folic acid
Neetu Tyagi (Louisville/US)
Homocysteine effect on osteoporosis
Eleftherios Paschalis (Vienna/AT)
Plenary Session 6 • B-Vitamins & Diabetes and renal dysfunction & CVD
Disturbance of thiamine metabolism in diabetes and the development and treatment of diabetic vascular complications
Paul J. Thornalley (Penrith/AU)
Intracellular cobalamin status in diabetes and polyneuropathy
Rima Obeid (Homburg/Saar/DE)
Mechanisms of H2S signalling in hemodialysis
Alessandra Perna (Naples/IT)
Plenary Session 7 • B-Vitamins and Choline: Pre- and postnatal Health
Molecular mechanisms of B-vitamin deficiency in neural tube defects and other birth defects
Henk Blom (Amsterdam/NL)
Folic acid supplementation during pregnancy and cancer risk in the offspring
Young-In Kim (Toronto/CA)
Genetic and nutritional variation in one-carbon metabolism influences reproductive outcomes
Rima Rozen (Montreal/CA)
Plenary Session 8 • Nutrients as methyl donors
Betaine, both a methyl donor and an osmolyte
Michael Lever (Christchurch/NZ)
Metabolic and Functional Effects of Choline in Cystic Fibrosis
Sheila Innis (Vancouver/CA)
Choline intake and cancer risk: epidemiologic studies
Eunyoung Cho (Boston/US)
Plenary Session 9 • Advances in Choline Research
Choline metabolism is related to endoplasmiceticulim stress response in vascular- and metabolic disease
Gerd Schmitz (Regensburg/DE)
Choline and the brain
Jan Blusztajn (Boston/US)
Fatty acid metabolism in choline and methionine deficiency
David McFarland (Dundee/UK)
Choline - containing phospholipids on brain functional pathways
Seyed K. Tayebati (Camerino/IT)
Plenary Session 10 • B-Vitamins and choline: Alcohol and liver function
Methionine metabolism in liver diseases
Kusum Kharbanda (Omaha/US)
B-Vitamin Dependent Methionine Metabolism in Pathogenesis, Prevention, and Treatment of Alcoholic Liver Disease
Charles Halsted (Davis/US)
Choline as a treatment for fetal alchohol spectrum disorders
Jennifer Thomas (San Diego/US)
Homocysteine in alcoholic liver disease
Donald Jacobsen (Cleveland/US)
Plenary Session 11 • (Epi)genetics, Diseases: The role of nutrients
Epigenetics and Choline
Steven Zeisel (Kannapolis/US)
Epigenomics effects of deficiency in methyl donors
Jean-Louis Guéant (Nancy-Vandoeuvre/FR)
The role of epigenetics in neurodegeneration
Andrea Fuso (Roma/IT)
Varied maternal choline intake in humans alters metabolic, epigenomic and epigenetic marks
Marie Claudill (Ithaca/US)
Plenary Session 12 • Concerns on B-Vitamin supplementation
Folate Intake Modulates Carcinogenesis: Mechanisms and Consequences
Joel Mason (Boston/US)
Renal function determines response to B vitamin therapy for homocysteine
David Spence (London/CA)
Diet as source of methyl donors nutrients: from raw to "ready-to-eat" foods
Gregorio Varela Moreiras (Boadilla del Monte/ES)
Plenary Session 13 • Molecular mechanisms
Cellular damage by homocysteine; the role of protein N-homocysteinylation
Hieronim Jakubowski (Newark/US)
Homocysteine and ADMA Influence Cerebrovascular and Myocardial Function through distinct mechanisms
Steven Lentz (Iowa/CA)
Folic acid and homocysteine: from coronary vasodilation to neuroprotection
Dragan Djuric (Belgrade/RS)
Immune activation and moderate hyperhomoysteinemia
Dietmar Fuchs (Innsbruck/AT)
Further speaker
Kinetic Modelling of Storage Effects on Biomarkers Related to B-vitamin Status and One-Carbon Metabolism
Per Magne Ueland (Bergen/NO)
Last update: November 17, 2011
